Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Thromboelastography Analyzer Market Forecast: What Value Will The Market Reach By 2030?
The thromboelastography analyzer market has experienced substantial expansion in recent years. This market is projected to expand from $0.41 billion in 2025 to $0.45 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.2%. Historically, this expansion was driven by factors such as a greater occurrence of bleeding disorders, an uptick in surgical procedures, an increase in trauma and emergency incidents, the development of hospital infrastructure, and enhanced understanding of blood coagulation diagnostics.
The thromboelastography analyzer market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $0.7 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.5%. This projected growth is driven by several factors, including an increasing need for personalized medicine strategies, heightened investment in sophisticated diagnostic tools, the expanding elderly demographic, the broadening of critical care services, and the need for quick bedside testing options. Key trends anticipated during this period encompass a greater acceptance of point-of-care coagulation analysis, the development of multi-channel high-throughput analyzers, a heightened requirement for monitoring hemostasis in surgery and trauma, an increase in the use of disposable reagents and consumables, and the incorporation of thorough blood clotting evaluation within critical care settings.
Get A Free Sample Report With In-Depth Market Insights:
Thromboelastography Analyzer Market Growth Factors: What’s Supporting Expansion?
The expanding occurrence of trauma and emergency care incidents is anticipated to boost the growth of the thromboelastography analyzer market in the future. These cases involve critical medical scenarios with severe injuries or sudden life-threatening situations necessitating prompt medical intervention to prevent death or lasting incapacitation. The rise in trauma and emergency incidents is linked to factors such as an increase in road traffic accidents. An uptick in road traffic accidents is fueling the need for thromboelastography analyzers, as these instruments facilitate quick evaluation of coagulation in trauma patients, aiding in prompt bleeding control and enhancing emergency care results. For example, in September 2025, the National Health Services, a UK-based government health agency, reported 27.4 million accident and emergency attendances in 2024-25, marking a 4.0% rise from 2023-24. Consequently, the increasing frequency of trauma and emergency care cases is stimulating the expansion of the thromboelastography analyzer market.
Thromboelastography Analyzer Market Segment Breakdown: Which Categories Lead On Revenue?
The thromboelastography analyzer market covered in this report is segmented –
1) By Type: Single And Double Channel, Four Channels, Other Types
2) By Consumables Or Accessories: Disposable Test Cartridges, Reagent Kits, Sample Cups, Pipettes, Quality Control Materials, Blood Collection Tubes, Analyzer Accessories And Cables
3) By Technology: Conventional Thromboelastography (TEG), Rotational Thromboelastometry (ROTEM), Other Viscoelastic Hemostatic Assay (VHA) Technologies
4) By Application: Cardiovascular Surgery, Trauma And Emergency Care, Transplant Surgery, Obstetrics And Gynecology, Liver And Hematologic Disorders
5) By End-User: Hospitals And Surgical Centers, Diagnostic Laboratories, Maternal And Child Health Services, Other End-Users
Subsegments:
1) By Single And Double Channel: Single Sample Analysis, Dual Sample Analysis, Routine Coagulation Testing, Point Of Care Usage
2) By Four Channels: Multi Sample Parallel Analysis, High Throughput Testing, Advanced Clinical Diagnostics, Critical Care Monitoring
3) By Other Types: Portable Thromboelastography Systems, Research Oriented Systems, Customized Diagnostic Configurations
Thromboelastography Analyzer Market Industry Trends: What’s Reshaping Demand?
Leading companies in the thromboelastography analyzer market are concentrating on developing novel products, such as extended-use assay cartridges for viscoelastic testing systems, to enable wider clinical application and faster, more comprehensive coagulation profiling across diverse patient groups. These extended-use assay cartridges for viscoelastic testing systems are consumable testing modules designed to expand the diagnostic capabilities of thromboelastography analyzers by catering to specific clinical conditions and patient cohorts. For instance, in April 2024, Haemonetics Corporation, a US-based provider of medical technologies and solutions for blood management, announced the U.S. Food and Drug Administration (FDA) approval for its TEG 6s Global Hemostasis. This new cartridge received FDA 510(k) clearance to extend the system’s viscoelastic testing capabilities to fully heparinized patients undergoing adult cardiovascular surgeries and liver transplantation, enhancing its use in both laboratory and point-of-care settings. The Global Hemostasis-HN cartridge provides clinicians with comprehensive insights into a patient’s coagulation profile faster and with greater detail than conventional tests, supported by software that enables remote real-time result viewing and customizable alerts. This innovation helps clinicians make more informed treatment decisions in critical care scenarios where rapid, accurate hemostasis assessment is essential.
Thromboelastography Analyzer Market Top Companies Driving Competitive Growth
Major companies operating in the thromboelastography analyzer market are Medtronic plc, Werfen SA, Haemonetics Corporation, Lepu Medical Technology (Beijing) Co. Ltd, Helena Laboratories Corporation, Zircon Corp., Diagnostica Stago Inc., Hemosonics LLC, Chongqing Nanfang Instruments Co. Ltd., Medcaptain Medical Technology Co. Ltd., Render Biotech Co. Ltd., Sienco Inc., Framer Hemologix-Srl, Biomart Inc., Guizhou Jinjiu Biotech Co. Ltd., Xenometrix AG, Zhejiang Shengyu Medical Instrument Co. Ltd., Beijing WITEYE Biotechnology Co. Ltd., UD-BIO, Beijing Succeeder Technology Inc., Sycomed E.K.
View The Full Thromboelastography Analyzer Market Report:
Thromboelastography Analyzer Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the thromboelastography analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thromboelastography analyzer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model